Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eur Heart J ; 39(36): 3396, 2018 09 21.
Article in English | MEDLINE | ID: mdl-29688402
2.
J Cardiovasc Surg (Torino) ; 59(3): 428-437, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28870062

ABSTRACT

BACKGROUND: Pulmonary thromboendarterectomy (PTE) is the treatment of choice for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, access to CTEPH and PTE care is limited. There is a paucity of published data on PTE efficacy and outcomes from alternative, regional centers of excellence in CTEPH and PTE care in the USA, outside a single national and international referral center. METHODS: We performed a retrospective review of patients undergoing PTE at our institution from June 2013 to December 2016 (42 months), and collected clinical, echocardiographic and hemodynamic data on our patients pre- and post-PTE (N.=71). RESULTS: Patients age ranged between 20-83 years (mean±SD: 56±16), with 54% of patients female and 61% Caucasians. The predominant symptom was shortness of breath with a median duration of symptoms of 17 months. Following PTE, clinical improvements included a reduction in NYHA class from 3.1±1.1 to 2.2±1.2. There were major improvements in hemodynamics and echocardiographic parameters pre- versus post-PTE: mean pulmonary artery pressure (mmHg) 45±11 to 24±8, cardiac index (L/min/m2) 2.1±0.5 to 2.8±0.5, pulmonary vascular resistance (mmHg/L/min) 8.9±4.5 to 2.8±1.8, ratio of right ventricle (RV): left ventricle (LV) 1.2±0.3 to 0.9±0.2, RV fractional area change (%) 23±14 to 44±13, reduction in the incidence of RV outflow tract Doppler notching and improved pulmonary artery acceleration time (96% to 30%, and 74±19 to 111±21). In-hospital mortality was 4.2% (3 patients). CONCLUSIONS: Herein, we report for the first time, the improvements in patient functionality, hemodynamics, right heart function and outcomes at a major regional PTE program.


Subject(s)
Arterial Pressure , Endarterectomy , Hypertension, Pulmonary/surgery , Pulmonary Artery/surgery , Pulmonary Embolism/surgery , Thrombectomy , Adult , Aged , Aged, 80 and over , Chronic Disease , Computed Tomography Angiography , Echocardiography, Doppler , Endarterectomy/adverse effects , Endarterectomy/mortality , Female , Hospital Mortality , Humans , Hypertension, Pulmonary/diagnostic imaging , Hypertension, Pulmonary/mortality , Hypertension, Pulmonary/physiopathology , Kaplan-Meier Estimate , Male , Middle Aged , Philadelphia , Postoperative Complications/etiology , Program Evaluation , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/physiopathology , Pulmonary Circulation , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/mortality , Pulmonary Embolism/physiopathology , Recovery of Function , Retrospective Studies , Risk Factors , Thrombectomy/adverse effects , Thrombectomy/mortality , Time Factors , Treatment Outcome , Vascular Resistance , Ventricular Function, Left , Ventricular Function, Right , Young Adult
4.
Curr Treat Options Cardiovasc Med ; 17(8): 397, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26096624

ABSTRACT

OPINION STATEMENT: Accurate assessment of cardiac function by transthoracic echocardiography (TTE) plays an essential role in clinical cardiology. While left ventricular ejection fraction (LVEF) assessment has traditionally been the most commonly used objective echocardiographic marker, many other echocardiographic parameters exist that permit an enhanced understanding of cardiac function. These range from 2-dimensional (2D) and 3-dimensional (3D) morphologic parameters to functional parameters such as wall strain and myocardial performance index. In this review, we survey a variety of TTE-based techniques that are utilized in practice to assess the systolic cardiac function of both the left and right ventricles.

6.
Clin Cardiol ; 38(6): 395-400, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25733325

ABSTRACT

Pulmonary arterial hypertension (PAH) is a rare disease, but it boasts significant morbidity and mortality. Although remarkable achievements have been made in the medical treatment of PAH, there is a role for invasive or surgical procedures in patients with progressive disease despite optimal medical therapy or with no access to such therapy. Atrial septostomy creates a right-to-left intracardiac shunt to decompress the overloaded right ventricle. Despite significant advances to validate and improve this palliative procedure, as well as recent reports of improved outcomes, it is only slowly being adopted. This article aims to detail the history, indications, contraindications, procedural techniques, and outcomes of atrial septostomy. We will also shed light on some of the newer interventions, inspired by the same physiological concept, that are being evaluated as potential palliative modalities in patients with PAH.


Subject(s)
Atrial Septum/surgery , Hypertension, Pulmonary/surgery , Adult , Child , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...